ROSIGLITAZONE vs ROZANOLIXIZUMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ROSIGLITAZONE vs ROZANOLIXIZUMAB: Safety Overview
| Metric | ROSIGLITAZONE | ROZANOLIXIZUMAB |
|---|---|---|
| Total FAERS Reports | 45,976 | 303 |
| Deaths Reported | 4,661 | 9 |
| Death Rate | 10.1% | 3.0% |
| Hospitalizations | 23,675 | 114 |
| Average Patient Age | 60.2 yrs | 61.3 yrs |
| % Female Patients | 42.8% | 60.9% |
| FDA Approval Date | Jan 25, 2013 | N/A |
| Manufacturer | N/A | UCB, Inc. |
| Route | N/A | SUBCUTANEOUS |
| Marketing Status | Discontinued | N/A |